ER-Positive mBC 19
b'Dissecting the Decision: Optimizing the Use of CDK4/6 Inhibitors in the Management of ER-Positive, HER2-Negative Metastatic Breast Cancer. Featuring a roundtable discussion with Drs Neelima Denduluri, Shom Goel, Erika Hamilton, Komal Jhaveri, Ruth M O\\u2019Regan and Sara M Tolaney. Moderated by Neil Love, MD. Produced by Research To Practice.'